In addition, PI3K and mTOR are essential regulators of radiation resistance in prostate cancer cells (Chang et al., 2014) as dual PI3K-mTOR inhibitors re-sensitize cancer cells to radiation treatment (Mukherjee et al., 2012). This evidence concerns the gene MTOR and Familial prostate cancer.